GSK To Roll Out £2B Share Buyback
Pharmaceutical giant GSK PLC on Wednesday said it will reward investors with a £2 billion ($2.5 billion) share repurchase program, as it reported stronger sales and increased investment towards its respiratory...To view the full article, register now.
Already a subscriber? Click here to view full article